Literature DB >> 12142351

Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.

Carmine Vecchione1, Ralf P Brandes.   

Abstract

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) improve endothelial function. We determined whether withdrawal of statin therapy affects endothelium-dependent relaxation in mice and studied the underlying mechanism. Mice were treated with daily injections of cerivastatin (2 mg/kg per day SC), atorvastatin (1 and 10 mg/kg per day SC), or placebo. Vascular reactivity was studied in aortic rings from these mice after 10 days of treatment and after cessation of therapy for several days. Both statins improved endothelium-dependent relaxation to acetylcholine. Compared with control, withdrawal of statin treatment transiently (from day 4 to 7) attenuated endothelium-dependent relaxation. In vessels from animals subjected to atorvastatin withdrawal, the antioxidant tiron restored relaxations. Vascular superoxide anion generation was unaffected by statin therapy but was increased during withdrawal. In mice lacking the gp91phox subunit of the NADPH oxidase, no attenuation of acetylcholine-induced relaxation and no increase in superoxide generation were observed after withdrawal of atorvastatin. In human umbilical vein endothelial cells, statins, which decrease the membrane association of NADPH oxidase-activating Rac-1, increased the activity of this GTPase in whole-cell lysates. Withdrawal of statins induced a translocation of Rac-1 from the cytosol to the membrane and transiently increased NADPH-induced lucigenin chemiluminescence in membrane preparations. Rac-1 inactivation by Clostridium difficile toxin B inhibited the cerivastatin-induced oxygen radical production in human umbilical vein endothelial cells. These observations indicate that the withdrawal of statins induces endothelial dysfunction. The underlying mechanism involves activation of a gp91phox-containing NADPH oxidase by Rac-1 and the subsequent scavenging of endothelium-derived NO by superoxide anions generated from this enzyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12142351     DOI: 10.1161/01.res.0000028004.76218.b8

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  33 in total

Review 1.  Statins and delirium: is there a role?

Authors:  Margarita Taburyanskaya; Tanna Hassig
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

Review 2.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 3.  Statins and the role of nitric oxide in chronic heart failure.

Authors:  Stephan von Haehling; Stefan D Anker; Eberhard Bassenge
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

4.  A novel mechanism of action for statins against diabetes-induced oxidative stress.

Authors:  C Vecchione; M T Gentile; A Aretini; G Marino; R Poulet; A Maffei; F Passarelli; A Landolfi; A Vasta; G Lembo
Journal:  Diabetologia       Date:  2007-02-06       Impact factor: 10.122

Review 5.  Good stress, bad stress--the delicate balance in the vasculature.

Authors:  Kirstin Wingler; Harald H H W Schmidt
Journal:  Dtsch Arztebl Int       Date:  2009-10-16       Impact factor: 5.594

6.  Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.

Authors:  Ibrahim R Hanna; Brent Heeke; Heather Bush; Lynne Brosius; Diane King-Hageman; Samuel C Dudley; John F Beshai; Jonathan J Langberg
Journal:  Heart Rhythm       Date:  2006-05-09       Impact factor: 6.343

Review 7.  NADPH oxidases as therapeutic targets in ischemic stroke.

Authors:  Timo Kahles; Ralf P Brandes
Journal:  Cell Mol Life Sci       Date:  2012-05-23       Impact factor: 9.261

8.  Effect of long- and short-term treatments with pravastatin on diabetes mellitus and pancreatic fibrosis in the Otsuka-Long-Evans-Tokushima fatty rat.

Authors:  M Otani; M Yamamoto; M Harada; M Otsuki
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

Review 9.  Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2.

Authors:  Timo Kahles; Ralf P Brandes
Journal:  Antioxid Redox Signal       Date:  2012-08-20       Impact factor: 8.401

10.  Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors.

Authors:  Stephanie J Turner; Shunhui Zhuang; Tong Zhang; Gerry R Boss; Renate B Pilz
Journal:  Biochem Pharmacol       Date:  2007-09-01       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.